Newscope Announces Name Change

TORONTO, April 08, 2021 (GLOBE NEWSWIRE) -- Newscope Capital Corporation (the “Company”) (CSE: PHRM) (OTCQB: PHRRF) is pleased to announce that it has filed an alteration notice with BC Registry Services changing the name of the Company to PharmaTher Holdings Ltd. The name change was approved by the Company’s shareholders at the special meeting held on April 5, 2021. The Company will be filing the necessary documentation with the CSE in order to commence trading under its new name.

There is no change in the share capital of the Company or its trading symbol, and shareholders are not required to exchange their existing share certificates for new certificates.

About Newscope Capital Corporation

Newscope Capital Corporation is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat neuropsychiatric, neurodegenerative and pain disorders.

Learn more at: PharmaTher.com and follow us on Twitter and LinkedIn.

For more information, please contact:

Fabio Chianelli Chief Executive Officer Newscope Capital Corporation Tel: 1-888-846-3171 Email: [email protected] Website: www.pharmather.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.

Source: Newscope Capital Corporation

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides
• Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth
• ALWAYS BEST CARE NAMES FRANCHISE MARKETING VETERAN RACHEL VAUGHN CHIEF MARKETING OFFICER